Comment on

• Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.

  Chesney MA, Lurie P, Coates TJ. Chesney MA, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):30-5. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7712232 Review. No abstract available.
• Incentives and disincentives to participate in prophylactic HIV vaccine research.

  Jenkins RA, Temoshok LR, Virochsiri K. Jenkins RA, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):36-42. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7712233